AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.100
-0.070 (-3.23%)
Aug 7, 2025, 4:00 PM - Market closed
AC Immune Market Cap
AC Immune has a market cap or net worth of $205.80 million as of August 8, 2025. Its market cap has decreased by -43.88% in one year.
Market Cap
205.80M
Enterprise Value
179.64M
1-Year Change
-43.88%
Ranking
Category
Stock Price
$2.10
Market Cap Chart
Since September 23, 2016, AC Immune's market cap has decreased from $867.50M to $205.80M, a decrease of -76.28%. That is a compound annual growth rate of -14.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 208.90M | -22.51% |
| Dec 31, 2024 | 269.60M | -36.36% |
| Dec 29, 2023 | 423.60M | 145.85% |
| Dec 30, 2022 | 172.30M | -52.25% |
| Dec 31, 2021 | 360.80M | -2.88% |
| Dec 31, 2020 | 371.50M | -35.46% |
| Dec 31, 2019 | 575.60M | 6.20% |
| Dec 31, 2018 | 542.00M | -25.42% |
| Dec 29, 2017 | 726.70M | 1.07% |
| Dec 30, 2016 | 719.00M | -17.12% |
| Sep 23, 2016 | 867.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.04B |
| Johnson & Johnson | 410.84B |
| AbbVie | 346.78B |
| AstraZeneca | 228.71B |
| Abbott Laboratories | 227.88B |
| UnitedHealth Group | 222.96B |
| Novartis AG | 221.76B |
| Novo Nordisk | 200.63B |